SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE ON PERSISTENCE, SWITCHING, AND DOSE ESCALATION WITH BIOLOGICS IN INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES

被引：0
|
作者：
Rupniewska, E. [1 ]
Singer, D. [2 ]
Khan, S. [3 ]
Neighbors, M. [3 ]
Chiarappa, J. A. [2 ]
Obando, C. A. [4 ]
机构：
[1] RTI Hlth Solut, Manchester, Lancs, England
[2] Janssen Sci Affairs, Titusville, NJ USA
[3] RTI Hlth Solut, Durham, NC USA
[4] Janssen Sci Affairs, Horsham, PA USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI35
引用
收藏
页码：S87 / S88
页数：2
相关论文
共 50 条
  • [1] Real-world evidence on adherence, persistence, switching and dose escalation with biologics in adult inflammatory bowel disease in the United States: A systematic review
    Khan, Shahnaz
    Rupniewska, Ewa
    Neighbors, Mackenzie
    Singer, David
    Chiarappa, Joseph
    Obando, Camilo
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (04) : 495 - 507
  • [2] SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE ON ADHERENCE WITH BIOLOGICS IN INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES
    Rupniewska, E.
    Singer, D.
    Khan, S.
    Neighbors, M.
    Chiarappa, J. A.
    Obando, C. A.
    [J]. VALUE IN HEALTH, 2018, 21 : S87 - S87
  • [3] Dose escalation and switching of biologics in ulcerative colitis: a systematic literature review in real-world evidence
    Gemayel, Nathalie C.
    Rizzello, Eugenio
    Atanasov, Petar
    Wirth, Daniel
    Borsi, Andras
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (11) : 1911 - 1923
  • [4] Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review
    Patel, Dipen
    Martin, Stephan
    Luo, Michelle
    Ursos, Lyann
    Lirio, Richard A.
    Kamble, Pravin
    Wang, Song
    [J]. CROHNS & COLITIS 360, 2022, 4 (03)
  • [5] Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis
    Singh, Harpreet
    Wilson, Liam
    Tencer, Tom
    Kumar, Jinender
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023, 15 : 125 - 138
  • [6] Real-world dose escalation of biologics for moderate-to-severe psoriasis in the United States
    Wu, Jashin J.
    Patel, Manish
    Zeng, Feng
    Huang, Ahong
    Pan, Xing
    Cao, Yiwen
    Chen, Naijun
    Photowala, Huzefa
    Garg, Vishvas
    Crowley, Jeff
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [7] Vedolizumab dose escalation in patients with inflammatory bowel disease experiencing loss of response: A systematic review and meta-analysis of real-world evidence
    Varghese, D.
    Patel, D.
    Martin, S.
    Luo, M.
    Ursos, L.
    Lirio, R.
    Wang, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S524 - S525
  • [8] VEDOLIZUMAB DOSE ESCALATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE EXPERIENCING LOSS OF RESPONSE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF REAL-WORLD EVIDENCE
    Varghese, Della
    Patel, Dipen
    Martin, Stephan
    Luo, Michelle
    Ursos, Lyann
    Lirio, Richard A.
    Wang, Song
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S406 - S407
  • [9] Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY
    Cleveland, Noa Krugliak
    Ghosh, Sabyasachi
    Chastek, Benjamin
    Bancroft, Tim
    Candela, Ninfa
    Fan, Tao
    Umashankar, Kandavadivu
    Rubin, David T.
    [J]. INFLAMMATORY BOWEL DISEASES, 2023,
  • [10] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Brian Bressler
    Jennifer Jones
    Tracy S. H. In
    Tommy Lan
    Cristian Iconaru
    John K. Marshall
    [J]. Advances in Therapy, 2023, 40 : 4421 - 4439
12345